Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer: A multicenter open-label cohort study (NABGEM cohort study)

Open Label

Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study

The Lancet Gastroenterology & Hepatology ◽

10.1016/s2468-1253(19)30327-9 ◽

2020 ◽

Vol 5 (3) ◽

pp. 285-294 ◽

Cited By ~ 14

Author(s):

Philip A Philip ◽

Jill Lacy ◽

Fabienne Portales ◽

Alberto Sobrero ◽

Roberto Pazo-Cid ◽

...

Keyword(s):

Pancreatic Cancer ◽

Locally Advanced ◽

Phase 2 ◽

Open Label ◽

Phase 2 Study ◽

Open Label Phase

OncoPaC-1: An Open-label, Single-Arm Pilot Study of Phosphorus-32 Microparticles Brachytherapy in Combination with Gemcitabine +/- Nab-Paclitaxel in Unresectable Locally Advanced Pancreatic Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2019.06.2010 ◽

2019 ◽

Vol 105 (1) ◽

pp. E236-E237 ◽

Cited By ~ 1

Author(s):

M.S. Bhutani ◽

J.B. Klapman ◽

R. Tuli ◽

G.E. El-Haddad ◽

S. Hoffe ◽

...

Keyword(s):

Pancreatic Cancer ◽

Pilot Study ◽

Locally Advanced ◽

Open Label

An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine +/- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocol

Endoscopic Ultrasound ◽

10.4103/eus.eus_44_19 ◽

2020 ◽

Vol 9 (1) ◽

pp. 24 ◽

Cited By ~ 2

Author(s):

ManoopS Bhutani ◽

JosephM Herman ◽

JasonB Klapman ◽

Richard Tuli ◽

Ghassan El-Haddad ◽

...

Keyword(s):

Pancreatic Cancer ◽

Pilot Study ◽

Study Protocol ◽

Locally Advanced ◽

Open Label ◽

Technical Details

FOLFIRINOX and radiotherapy for locally advanced pancreatic cancer: A cohort study

Journal of Surgical Oncology ◽

10.1002/jso.25233 ◽

2018 ◽

Vol 118 (6) ◽

pp. 1021-1026 ◽

Cited By ~ 9

Author(s):

Mustafa Suker ◽

Joost J. Nuyttens ◽

Bas Groot Koerkamp ◽

Ferry A. L. M. Eskens ◽

Casper H. J. van Eijck

Keyword(s):

Pancreatic Cancer ◽

Cohort Study ◽

Locally Advanced ◽

Locally Advanced Pancreatic Cancer

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial

The Lancet Oncology ◽

10.1016/s1470-2045(16)00078-4 ◽

2016 ◽

Vol 17 (5) ◽

pp. 651-662 ◽

Cited By ~ 243

Author(s):

Timothy M Nywening ◽

Andrea Wang-Gillam ◽

Dominic E Sanford ◽

Brian A Belt ◽

Roheena Z Panni ◽

...

Keyword(s):

Pancreatic Cancer ◽

Locally Advanced ◽

Dose Finding ◽

Single Centre ◽

Open Label ◽

Borderline Resectable ◽

Label Dose ◽

Phase 1B

1060 RESECTION RATE AND SURVIVAL AFTER NEOADJUVANT THERAPY FOR BORDERLINE RESECTABLE AND LOCALLY ADVANCED PANCREATIC CANCER: A PROSPECTIVE COHORT STUDY

Gastroenterology ◽

10.1016/s0016-5085(20)34561-3 ◽

2020 ◽

Vol 158 (6) ◽

pp. S-1552

Author(s):

Simone Serafini ◽

Lucia Moletta ◽

Elisa Sefora Pierobon ◽

Alberto Ponzoni ◽

Giovanni Capovilla ◽

...

Keyword(s):

Pancreatic Cancer ◽

Cohort Study ◽

Neoadjuvant Therapy ◽

Prospective Cohort Study ◽

Prospective Cohort ◽

Locally Advanced ◽

Resection Rate ◽

Borderline Resectable

Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study

Cancer Research and Treatment ◽

10.4143/crt.2015.226 ◽

2016 ◽

Vol 48 (3) ◽

pp. 1045-1055 ◽

Cited By ~ 6

Author(s):

Younak Choi ◽

Do-Youn Oh ◽

Kyubo Kim ◽

Eui Kyu Chie ◽

Tae-Yong Kim ◽

...

Keyword(s):

Pancreatic Cancer ◽

Cohort Study ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Concurrent Chemoradiotherapy ◽

Locally Advanced ◽

Locally Advanced Pancreatic Cancer

HGCSG1601: A retrospective cohort study of the efficacy and safety of nab-paclitaxel plus gemcitabine (nab-P+GEM) for unresectable locally advanced pancreatic cancer (LAPC)

Annals of Oncology ◽

10.1093/annonc/mdz422.071 ◽

2019 ◽

Vol 30 ◽

pp. ix65

Author(s):

A. Tanimoto ◽

M. Yagisawa ◽

S. Nakano ◽

Y. Kawamoto ◽

S. Yuki ◽

...

Keyword(s):

Pancreatic Cancer ◽

Cohort Study ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Locally Advanced ◽

Efficacy And Safety

Induction Chemotherapy Followed by Resection or Irreversible Electroporation in Locally Advanced Pancreatic Cancer (IMPALA): A Prospective Cohort Study

Annals of Surgical Oncology ◽

10.1245/s10434-017-5900-9 ◽

2017 ◽

Vol 24 (9) ◽

pp. 2734-2743 ◽

Cited By ~ 39

Author(s):

Jantien A. Vogel ◽

Steffi J. Rombouts ◽

Thijs de Rooij ◽

Otto M. van Delden ◽

Marcel G. Dijkgraaf ◽

...

Keyword(s):

Pancreatic Cancer ◽

Cohort Study ◽

Induction Chemotherapy ◽

Prospective Cohort Study ◽

Prospective Cohort ◽

Locally Advanced ◽

Irreversible Electroporation ◽

Locally Advanced Pancreatic Cancer

PanCO: Updated Results of an Open-Label, Single-Arm Pilot Study of OncoSil P-32 Microparticles in Combination with Standard-of-Care (SoC) Gemcitabine + Nab-Paclitaxel or FOLFIRINOX Chemotherapy in Unresectable Locally Advanced Pancreatic Cancer (uLAPC)

Pancreatology ◽

10.1016/j.pan.2020.10.007 ◽

2020 ◽

Vol 20 (8) ◽

pp. e16

Author(s):

Paul Ross ◽

Alain Hendlisz ◽

Thankamma Ajithkumar ◽

Chinenye Iwuji ◽

Marion Harris ◽

...

Keyword(s):

Pancreatic Cancer ◽

Pilot Study ◽

Locally Advanced ◽

Standard Of Care ◽

Open Label